PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pepmetics Inc., 772 Murphy Place, Victoria, BC V8Y 3H4, Canada.\', \'Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada.\', \'Department of Physics, Federal University of Espirito, Santo, Vitoria 29075-910, Brazil.\', \'NewDrug, Patras Science Park, 26500 Patras, Greece.\', \'Institute for Health and Sport, Victoria University, Melbourne, VIC 3030, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 97910.3390/biom11070979
?:doi
?:hasPublicationType
?:journal
  • Biomolecules
is ?:pmid of
?:pmid
?:pmid
  • 34356603
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.552
?:rankingScore_hIndex
  • 28
is ?:relation_isRelatedTo_publication of
?:title
  • Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers-Relevance to COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34356603>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34356603>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all